Anzeige
Mehr »
Mittwoch, 27.08.2025 - Börsentäglich über 12.000 News
Patentschutz bis in die 2040er - Biotech-Geheimtipp vor möglichem Fast-Track-Durchbruch in den USA!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
210 Leser
Artikel bewerten:
(1)

Revolutionizing Regtech: LighthouseAI Secures Strategic Investment and Landmark Law Firm Partnership

LighthouseAI Set to Impact the Regulatory Technology Industry with AI-driven Compliance

LOS ANGELES, CA / ACCESSWIRE / November 16, 2023 / LighthouseAI, an industry leader in compliance solutions for the pharmaceutical supply chain with over 8 years of experience and over 700 clients engaged, today announced their first partnership under their Certified Law Firm Partner Program which enables law firms to incorporate LighthouseAI in their traditional workflows. The successful partnership signing underscores the recent investment from The Legal Tech Fund which will accelerate the development of its AI technology, as well as expand its reach to assist law firms to reduce the time and costs associated with their pharmaceutical clients' supply chain compliance actions.

LighthouseAI's new Certified Law Firm Partner Program enables law firms to leverage LighthouseAI Intelligence to increase practice profitability by reducing the time and cost associated with manual regulatory research and change assessments while maintaining rates. The program provides law firms access to LighthouseAI's AI-powered platform to deliver more efficient and cost-effective counsel to pharmaceutical supply chain clients. As a part of this announcement, LighthouseAI welcomes its first Certified Law Firm Program Partner, Boesen & Snow, a law firm recognized as a national leader in the health industry.

Allyson Snow, Partner and Co-founder of Boeson & Snow, commented: "Boesen & Snow is a firm that prides itself on assembling a team of counsel and professionals who have decades of hands-on healthcare operations experience. We are pleased to be the first Certified Law Firm Program Partner to LighthouseAI and look forward to complimenting their AI-driven solutions."

Sumeet Singh, CEO of LighthouseAI, said, "Assessments on compliance requirements for pharma supply chain and pharmacies has historically been a manual process, with lawyers and experts simply brute forcing their way through 50+ jurisdictions. To solve this challenge, we developed LighthouseAI Intelligence to bridge the practical applicability gap between regulatory content and regulatory knowledge. Law firms can layer their legal services atop our proprietary technology, which will remove the need to perform such laborious tasks and ultimately allow them to focus on high-value work, reduce the cost to their clients, and increase speed for the completion of a project."

This strategic investment from The Legal Tech Fund will enable LighthouseAI to continue enhancing its technology and datasets, expanding into new use cases, and forming partnerships with law firms seeking to leverage AI to improve efficiency, reduce costs, and deliver higher-value services.

Zach Posner, Managing Partner at The Legal Tech Fund, said: "We are excited by the work of Lighthouse AI and the innovation they are bringing to the pharmaceutical compliance space. Our investment aligns with our vision to support transformative solutions that not only reduce regulatory burdens but also empower law firms to deliver unparalleled value to their clients in navigating complex compliance landscapes."

***

About LighthouseAI

LighthouseAI specializes in AI-driven solutions to navigate the complex landscape of regulatory compliance in the life sciences supply chain. With over 8 years of experience, 700 clients, and recognition as thought-leaders, LighthouseAI delivers a SaaS solution that ensures seamless alignment with life sciences compliance regulations, protecting revenue and reducing costs and risks. By eliminating human error and delivering quick, efficient compliance solutions, LighthouseAI revolutionizes the traditional methods of adherence to life sciences regulations. Learn more about how LighthouseAI is shaping the future of regulatory compliance at www.LighthouseAI.com.

Contact Information

Ryan Hall
Marketing Manager
ryan.hall@lighthouseai.com
(610) 298-5247

SOURCE: LighthouseAI

.

View source version on accesswire.com:
https://www.accesswire.com/803909/revolutionizing-regtech-lighthouseai-secures-strategic-investment-and-landmark-law-firm-partnership

© 2023 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.